This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Drug Delivery Remove In-Vitro Remove Pharma Companies Related Topics
Reagent In-Vivo Genetic Disease Doctors Gene Editing Life Science DNA Gene Therapy Clinical Research Medicine More Related Topics >
article thumbnail

Turning science into business: An optimised alternative to antibodies

Drug Discovery World

APRIL 3, 2023

From humble beginnings in the founder’s basement, UK-based Aptamer Group is now supplying its Optimer binders to clients across big pharma. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies. DDW’s Diana Spencer caught up with co-founder and CEO Dr Arron Tolley.

Antibody 52
Antibody Gene Therapy Gene In-Vitro 52
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

OCTOBER 1, 2020

To gain insight into the motivations, steps and experiences involved in an academia to industry — or vice versa — transition, Xtalks spoke to several leading scientists and entrepreneurs in pharma and biotech who successfully transitioned from academic positions to leadership roles in industry settings. Key Moments.

Scientist 52
Scientist In-Vitro Research Life Science 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024